Total Funding
46
12
Total FundingSeed raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
306243
Marker of the Urine Malaria Test (UMT) Rapid Malaria Diagnositic.
Anne Derrick: Vice President, Business Development and Operations
Eddy Agbo: Chairman & CEO
About the Company
Fyodor is a privately held medical device company whose mission is to develop and commercialize novel medical diagnostic tests that address unmet needs in Nigeria and emerging economies. In response to the large proportion of malaria that is managed at home and in all healthcare settings, Fyodor has developed the Urine Malaria TestTM (UMT) – the
first ever non-blood (one-step, no blood, no reagents, no equipment, visually read) rapid test that tells in 25 minutes or less if a fever is due to malaria or not. It removes the complexity, pain and risks associated with a blood test.
